Literature DB >> 28690292

Atrial Fibrillation on Admission Is Related With Higher Mortality in ST-Segment Elevation Myocardial Infarction Patients.

Kyung-Kuk Hwang1,2, Sang-Yong Eom3, Sang Yeub Lee1, Sang Min Kim1, Myeong-Chan Cho1,2, Young Jo Kim4, Ki Bae Seung5, Myung Ho Jeong6, Jang-Whan Bae1,2.   

Abstract

The prognostic significance of atrial fibrillation (AF) on mortality in ST-segment elevation myocardial infarction (STEMI) patients is not clearly understood. To elucidate the clinical significance of AF on mortality for 1 year in STEMI patients, we retrospectively analyzed the Korea Acute Myocardial Infarction Registry (KAMIR) database, which spans January 2008 to September 2010 and includes 14,329 patients with acute myocardial infarction. We selected 5,556 patients with marked ECG rhythm (NSR, normal sinus rhythm or AF) on emergency room arrival, < 12 hours of symptom onset, and who underwent primary percutaneous coronary intervention (PCI) within 90 minutes of arriving at the hospital. Patients who had been followed-up for at least for 1 year were analyzed (2,636 of NSR, 119 of AF). At enrollment, AF patients were older (70.7 versus 65.5 years, P < 0.001) and had lower systolic blood pressure (120.6 versus 125.9 mmHg, P = 0.050), a higher heart rate (80.4 versus 75.6/minute, P = 0.009), and a higher rate of Killip III, IV (25.0 versus 14.2%, P = 0.002). Patients with AF showed clearly higher all-cause mortality (22.7 versus 9.5%, HR 2.51, 95%CI 1.68~3.76, P < 0.001) and cardiac death rate (17.7 versus 7.5%, HR 2.49, 95%CI 1.59~3.90, P < 0.001) at 1 year after admission compared patients with NSR. AF induced significantly higher all-cause mortality and cardiac mortality rate in STEMI patients who were appropriately revascularized with primary PCI compared to NSR at 1 year.

Entities:  

Keywords:  Major adverse cardiac event; Normal sinus rhythm; Target lesion revascularization

Mesh:

Year:  2017        PMID: 28690292     DOI: 10.1536/ihj.16-286

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  4 in total

1.  Effects of atrial fibrillation on complications and prognosis of patients receiving emergency PCI after acute myocardial infarction.

Authors:  Yingchun Zhang; Lingzhi Zhang; Hongzhi Zheng; Hongfen Chen
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

2.  Serum YKL-40 positively correlates with MMP-9 and CRP in patients with acute ST segment elevation myocardial infarction following emergency treatment.

Authors:  Yuanfei Tan; Xiaoying Ji; Zhifeng Mo; Yaoliang Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.

Authors:  Simone Rivolo; Manuela Di Fusco; Carlos Polanco; Amiee Kang; Devender Dhanda; Mirko Savone; Aristeidis Skandamis; Thitima Kongnakorn; Javier Soto
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

4.  The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients.

Authors:  Eero Anttonen; Olli Punkka; Joonas Leivo; Sanjit S Jolly; Vladimír Džavík; Jyri Koivumäki; Minna Tahvanainen; Kimmo Koivula; Kjell Nikus; Jia Wang; John A Cairns; Kari Niemelä; Markku Eskola
Journal:  CJC Open       Date:  2021-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.